238 related articles for article (PubMed ID: 36090319)
1. The prognostic value of systemic immune-inflammation index in surgical esophageal cancer patients: An updated meta-analysis.
Li X; Zhang S; Lu J; Li C; Li N
Front Surg; 2022; 9():922595. PubMed ID: 36090319
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of pretreatment systemic immune-inflammation index in Chinese esophageal squamous cell carcinoma patients receiving radical radiotherapy: A meta-analysis.
Zeng X; Ye L; Luo M; Zeng D; Chen Y
Medicine (Baltimore); 2023 Jun; 102(25):e34117. PubMed ID: 37352061
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis.
Meng L; Yang Y; Hu X; Zhang R; Li X
J Transl Med; 2023 Feb; 21(1):79. PubMed ID: 36739407
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of systemic immune-inflammation index in patients with ovarian cancer: a meta-analysis.
Mao H; Yang F
Front Oncol; 2023; 13():1193962. PubMed ID: 37342198
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of systemic immune-inflammation index in patients with urinary system cancers: a meta-analysis.
Wang Q; Zhu SR; Huang XP; Liu XQ; Liu JB; Tian G
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1302-1310. PubMed ID: 33629300
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of the pretreatment systemic immune-inflammation index (SII) in patients with non-small cell lung cancer: a meta-analysis.
Wang Y; Li Y; Chen P; Xu W; Wu Y; Che G
Ann Transl Med; 2019 Sep; 7(18):433. PubMed ID: 31700869
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of systemic immune-inflammation index in patients with nasopharyngeal carcinoma: a meta-analysis.
Zeng Z; Xu S; Wang D; Qin G
Syst Rev; 2022 Nov; 11(1):247. PubMed ID: 36403072
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis.
Zhang Y; Sun Y; Zhang Q
Cancer Cell Int; 2020; 20():224. PubMed ID: 32528232
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis.
Huang Y; Gao Y; Wu Y; Lin H
Cancer Cell Int; 2020; 20():499. PubMed ID: 33061851
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinical pathological significance of the systemic immune-inflammation index in urothelial carcinoma: a systematic review and meta-analysis.
Wang Y; Hao X; Li G
Front Oncol; 2024; 14():1322897. PubMed ID: 38595827
[TBL] [Abstract][Full Text] [Related]
11. Systemic immune-inflammation index is a promising non-invasive biomarker for predicting the survival of urinary system cancers: a systematic review and meta-analysis.
Li X; Gu L; Chen Y; Chong Y; Wang X; Guo P; He D
Ann Med; 2021 Dec; 53(1):1827-1838. PubMed ID: 34647517
[TBL] [Abstract][Full Text] [Related]
12. High systemic immune-inflammation index predicts poor prognosis and response to intravesical BCG treatment in patients with urothelial carcinoma: a systematic review and meta-analysis.
Liu W; Zhang Y; Wang M; Wang M; Yang Q
Front Oncol; 2023; 13():1229349. PubMed ID: 38023187
[TBL] [Abstract][Full Text] [Related]
13. Preoperative systemic immune-inflammation index as a prognostic indicator for patients with urothelial carcinoma.
Zheng J; Peng L; Zhang S; Liao H; Hao J; Wu S; Shen H
Front Immunol; 2023; 14():1275033. PubMed ID: 38053997
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of the systemic immune-inflammation index in biliary tract cancers: a meta-analysis of 3,515 patients.
Zhang B; Yao W
World J Surg Oncol; 2022 Sep; 20(1):320. PubMed ID: 36171621
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of systemic immune-inflammation index in patients with pancreatic cancer: a meta-analysis.
Li M; Li Z; Wang Z; Yue C; Hu W; Lu H
Clin Exp Med; 2022 Nov; 22(4):637-646. PubMed ID: 35022918
[TBL] [Abstract][Full Text] [Related]
16. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma.
Gao Y; Guo W; Cai S; Zhang F; Shao F; Zhang G; Liu T; Tan F; Li N; Xue Q; Gao S; He J
J Cancer; 2019; 10(14):3188-3196. PubMed ID: 31289589
[No Abstract] [Full Text] [Related]
17. Prognostic and Clinicopathological Significance of the Systemic Immune-Inflammation Index in Patients With Renal Cell Carcinoma: A Meta-Analysis.
Jin M; Yuan S; Yuan Y; Yi L
Front Oncol; 2021; 11():735803. PubMed ID: 34950577
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of the Systemic Immune-Inflammation Index (SII) in Patients With Small Cell Lung Cancer: A Meta-Analysis.
Zhou Y; Dai M; Zhang Z
Front Oncol; 2022; 12():814727. PubMed ID: 35186750
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of pretreatment systemic immune-inflammation index in patients with prostate cancer: a meta-analysis.
Zhang B; Xu T
World J Surg Oncol; 2023 Jan; 21(1):2. PubMed ID: 36600256
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and clinicopathological impacts of systemic immune-inflammation index on patients with diffuse large B-cell lymphoma: a meta-analysis.
Fan Z; Shou L
Ther Adv Hematol; 2023; 14():20406207231208973. PubMed ID: 37954483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
